Hironori Koga
Department of Medicine
Kurume University School of Medicine
Kurume
Japan
Name/email consistency: high
- PPARγ potentiates anticancer effects of gemcitabine on human pancreatic cancer cells. Koga, H., Selvendiran, K., Sivakumar, R., Yoshida, T., Torimura, T., Ueno, T., Sata, M. Int. J. Oncol. (2012)
- Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells. Koga, H., Harada, M., Ohtsubo, M., Shishido, S., Kumemura, H., Hanada, S., Taniguchi, E., Yamashita, K., Kumashiro, R., Ueno, T., Sata, M. Hepatology (2003)
- Hepatocellular carcinoma: is there a potential for chemoprevention using cyclooxygenase-2 inhibitors?. Koga, H. Cancer (2003)
- Abnormal accumulation in lipopolysaccharide in biliary epithelial cells of rats with self-filling blind loop. Koga, H., Sakisaka, S., Yoshitake, M., Harada, M., Kumemura, H., Hanada, S., Taniguchi, E., Kawaguchi, T., Kumashiro, R., Sata, M. Int. J. Mol. Med. (2002)
- Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines. Koga, H., Sakisaka, S., Harada, M., Takagi, T., Hanada, S., Taniguchi, E., Kawaguchi, T., Sasatomi, K., Kimura, R., Hashimoto, O., Ueno, T., Yano, H., Kojiro, M., Sata, M. Hepatology (2001)
- Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Koga, H., Sakisaka, S., Ohishi, M., Kawaguchi, T., Taniguchi, E., Sasatomi, K., Harada, M., Kusaba, T., Tanaka, M., Kimura, R., Nakashima, Y., Nakashima, O., Kojiro, M., Kurohiji, T., Sata, M. Hepatology (1999)